Top compounds associated with response to WSCD2


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.14 0.003
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.003
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.003
mRNA Panobinostat CTRPv2 pan-cancer AAC -0.094 0.004
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.098 0.004
mRNA Topotecan CTRPv2 pan-cancer AAC -0.088 0.005
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC -0.1 0.005
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.005
Download CSV